29 November – 4 December 2015

18th ICASA
Harare, Zimbabwe


Past events

Expressions of Interest – Daclatasvir

MPP now invites Expressions of Interest from potential sub-licensees for licence to manufacture and sell formulations containing daclatasvir (DCV) in the respective Territory.
Instructions available on the Expression of Interest page

New agreements for TAF signed with Lupin and Micro Labs

View our sub-licensees section

Ensuring new medicines reach those in most need

Read MPP’s Executive Director, Greg Perry and Head of Policy, Esteban Burrone comment published in the latest issue of The Lancet HIV

ARV forcasts presented at IAS 2015

Forecasted demand for current and new ARV medicines in low- and middle-income countries, 2014-2025

UNITAID and MPP publish ARV Snapshot Report

See the report

MPP Newsletter July 2015

Review our progress over the past months: new publications, events & more


Progress and Achievements Report

MPP highlights milestones of first 5 years

MPP 2014 Annual Report

Read about the MPP’s 2014 achievements


Watch a Video Interview with G. Perry

How to convince big pharma to share intellectual property to improve global health


Recent Achievements and Impact

The MPP by the numbers and more